Human Urine Sample Collection for Alport Nephropathy Biomarker Studies
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01602835|
Recruitment Status : Terminated
First Posted : May 21, 2012
Last Update Posted : February 11, 2014
This is a prospective cross-sectional, observational, single-center study of Alport patients, in which a single, first morning voided urine collection will be acquired and used to validate assays of urine biomarkers that reflect changes in glomerular protein filtration barrier function.
The purpose of this study is to identify biomarkers indicative of changes in glomerular filtration function that occur during the course of proteinuric renal diseases such as Alport nephropathy.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||80 participants|
|Official Title:||Human Urine Sample Collection for Alport Nephropathy Biomarker Studies|
|Study Start Date :||September 2012|
|Primary Completion Date :||May 2013|
|Study Completion Date :||May 2013|